Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.

Date publication

juin 2018

Journal

Chinese clinical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine , Dr BOREL Christian , Pr NOEL Georges , Dr BURGY Mickaël

Tous les auteurs :
Ohnleiter T, Antoni D, Lefebvre F, Truntzer P, Schultz P, Burgy M, Borel C, Noël G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30180748

Résumé

Patients with secondary/recurrent squamous cell head and neck cancer have poor prognoses. Re-irradiation is a treatment option. However, best technique to re-irradiate is not known. This study aims to evaluate the outcome of patients treated with curative-intent intensity-modulated radiotherapy (IMRT) re-irradiation (re-RT) for head and neck (H&N) cancers.

Mots clés

Head and neck cancer (H&N cancer), intensity-modulated radiotherapy(IMRT), prognostic factors, re-irradiation (re-RT)

Référence

Chin Clin Oncol. 2018 Jun 27;: